Inventor · disambiguated record
Ronald J. Biediger
Also filed as: BIEDIGER RONALD · BIEDIGER RONALD J
25 granted patents·6 pending applications·328 citations·filing 1994–2022
96Inventor score
Files withUNIV FLORIDA STATE8TEXAS HEART INST7BIEDIGER RONALD J5ENCYSIVE PHARMACEUTICALS INC3TEXAS BIOTECHNOLOGY CORP3
Top patents by PatentIndex Score
31 records- 0196US5405972ASynthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1994·Granted Apr 11, 1995·79 cites·7 claims
- 0286US10246451B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2017·Granted Apr 2, 2019·7 cites·14 claims
- 0385US7579340B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsPFIZER·Filed 2007·Granted Aug 25, 2009·4 cites·6 claims
- 0485US6723711B2Propanoic acid derivatives that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 2001·Granted Apr 20, 2004·35 cites·13 claims
- 0585US5637732ATricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1995·Granted Jun 10, 1997·26 cites·11 claims
- 0683US6861537B2Tricyclic and tetracyclic taxane intermediatesUNIV FLORIDA STATE·Filed 2002·Granted Mar 1, 2005·8 cites·18 claims
- 0782US10494367B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2019·Granted Dec 3, 2019·4 cites·19 claims
- 0881US6194448B1N, N-disubstituted amides that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Feb 27, 2001·42 cites·17 claims
- 0980US6972296B2Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsENCYSIVE PHARMACEUTICALS INC·Filed 2001·Granted Dec 6, 2005·14 cites·8 claims
- 1079US5760252ASynthetic process for the preparation of tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1996·Granted Jun 2, 1998·17 cites·18 claims
- 1178US9512109B2Agonists that enhance binding of integrin-expressing cells to integrin receptorsBIEDIGER RONALD J·Filed 2011·Granted Dec 6, 2016·4 cites·1 claims
- 1278US5618952ASynthetic process for the preparation of tricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1995·Granted Apr 8, 1997·16 cites·11 claims
- 1374US7288538B2Phenylenediamine urotensin-II receptor antagonists and CCR-9 antagonistsENCYSIVE PHARMACEUTICALS INC·Filed 2004·Granted Oct 30, 2007·5 cites·7 claims
- 1474US6096773ACompounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP INC·Filed 1999·Granted Aug 1, 2000·33 cites·10 claims
- 1573US6005120ATricyclic and tetracyclic taxanesUNIV FLORIDA STATE·Filed 1997·Granted Dec 21, 1999·12 cites·16 claims
- 1671US7812038B2Carboxylic acid derivatives that inhibit the binding of integrins to their receptorsENCYSIVE PHARMACEUTICALS INC·Filed 2005·Granted Oct 12, 2010·1 cites·7 claims
- 1766US6262084B1Compounds that inhibit the binding of integrins to their receptorsTEXAS BIOTECHNOLOGY CORP·Filed 1999·Granted Jul 17, 2001·18 cites·10 claims
- 1863US2019210992A1Agonists that enhance binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2019·Application pending·0 cites
- 1962US6433189B2Tricyclic and tetracyclic taxane intermediatesUNIV FLORIDA STATE·Filed 2001·Granted Aug 13, 2002·2 cites·10 claims
- 2061US8178699B2Modulators of CCR9 receptor and methods of use thereofANDERSON ERIC C·Filed 2008·Granted May 15, 2012·0 cites·2 claims
- 2159US2025099423A1Piperazine-based agonists of lfa-1 and vla-4TEXAS HEART INST·Filed 2022·Application pending·0 cites
- 2257US10287264B2Agonists that enhance binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2016·Granted May 14, 2019·0 cites·8 claims
- 2357US2024360113A1Aminoaryl-integrin agonists compoundsTEXAS HEART INST·Filed 2022·Application pending·0 cites
- 2457US2024325340A1Isoform specific agonists targeting akt kinaseUNIV JEFFERSON·Filed 2022·Application pending·0 cites
- 2556US10071980B2Agonists that enhanced binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2015·Granted Sep 11, 2018·0 cites·3 claims
- 2654US10035784B2Agonists that enhanced binding of integrin-expressing cells to integrin receptorsTEXAS HEART INST·Filed 2015·Granted Jul 31, 2018·0 cites·3 claims
- 2753US2021393811A1Imaging Agents and Methods of UseTEXAS HEART INST·Filed 2019·Application pending·0 cites
- 2842US6278026B1Intermediates for tricyclic or tetracyclic taxanesUNIV FLORIDA STATE·Filed 1999·Granted Aug 21, 2001·1 cites·4 claims
- 2942US2008188528A1Modulators of C3a receptor and methods of use thereofBIEDIGER RONALD J·Filed 2007·Application pending·0 cites
- 3040US11312685B2Targeting nanoparticlesTEXAS CHILDRENS HOSPTIAL·Filed 2018·Granted Apr 26, 2022·0 cites·56 claims
- 3139US10875875B2Propionic acid derivatives and methods of use thereofBIEDIGER RONALD J·Filed 2017·Granted Dec 29, 2020·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →